- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03078244
Protocol for a Multicentre Survey of Patients With Treatment Resistant Hypertension (SPIRIT)
February 15, 2018 updated by: George Clinical Pty Ltd
Project aims to determine the number of individuals with treatment resistant hypertension and to define the characteristics of these patients and estimate disease frequency.
The study will be a retrospective review of medical record data based upon de-identified information and will require no patient contact.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
1500
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Adult subjects with treatment resistant hypertension
Description
Inclusion Criteria:
- > = 18 years of age
- No known secondary cause of hypertension
- History of uncontrolled hypertension while using 3 or more anti-hypertensive agents
- Controlled blood pressure using 4 or more different anti-hypertensive agents
Exclusion Criteria:
N/A
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Number of adult subjects with treatment resistant hypertension
Time Frame: one year
|
one year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2016
Primary Completion (Actual)
August 31, 2017
Study Completion (Actual)
August 31, 2017
Study Registration Dates
First Submitted
March 8, 2017
First Submitted That Met QC Criteria
March 8, 2017
First Posted (Actual)
March 13, 2017
Study Record Updates
Last Update Posted (Actual)
February 19, 2018
Last Update Submitted That Met QC Criteria
February 15, 2018
Last Verified
February 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ACHT41
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Treatment Resistant Hypertension
-
Duke UniversityCompletedTreatment-Resistant HypertensionUnited States
-
Duke UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedTreatment-Resistant HypertensionUnited States
-
Dr. Harindra WijeysunderaMedtronic; Mars Excellence in Clinical Innovation and Technology EvaluationTerminatedTreatment-Resistant HypertensionCanada
-
Entheon Biomedical Corp.CompletedTreatment-resistant DepressionUnited States
-
Changping LaboratoryBeijing HuiLongGuan HospitalRecruitingTreatment-Resistant DepressionChina
-
Central Institute of Mental Health, MannheimCharite University, Berlin, Germany; German Federal Ministry of Education and... and other collaboratorsActive, not recruitingTreatment-resistant DepressionGermany
-
Janssen Research & Development, LLCCompletedTreatment-resistant DepressionUnited States, Australia, France, United Kingdom, Belgium, Germany, Taiwan, Spain, Argentina, Mexico, Poland, Bulgaria, Malaysia, South Africa, Turkey, Finland, Korea, Republic of, Brazil, Austria, Sweden, Lithuania
-
Janssen Research & Development, LLCCompletedTreatment-resistant DepressionUnited States, France, Belgium, Mexico, Canada, Brazil, Estonia, Hungary, Slovakia
-
University of OttawaCanadian Institutes of Health Research (CIHR)Completed
-
All India Institute of Medical Sciences, BhubaneswarRecruitingTreatment Resistant SchizophreniaIndia
Clinical Trials on N/A, observational study
-
Center for Eye Research AustraliaRecruitingAge-related Macular Degeneration | Geographic Atrophy | Age Related Macular Degeneration | AMDAustralia
-
University of California, San FranciscoNational Institute of Neurological Disorders and Stroke (NINDS)Completed
-
Ohio State UniversityUSDA North Central - Nutrition Education Center of ExcellenceCompleted
-
VASCage GmbHMedical University Innsbruck; St John of God Hospital, ViennaRecruiting
-
Fondazione per la Ricerca Ospedale MaggioreCompletedBrain Injuries, Traumatic | Brain Injury Traumatic Severe | Brain Injury Traumatic ModerateItaly
-
University College DublinUniversity College CorkCompletedFood Consumption Database AnalysisIreland
-
University of North Carolina, CharlotteEunice Kennedy Shriver National Institute of Child Health and Human Development...Recruiting
-
University of Texas at AustinEnrolling by invitation
-
University of Colorado, DenverNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and other collaboratorsRecruitingRheumatoid ArthritisUnited States
-
St. Louis UniversityMid-America TransplantActive, not recruitingLiver Transplant Rejection | Liver Transplant Failure and RejectionUnited States